![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C12N 9/40 | (2006.01) |
A61K 38/47 | (2006.01) | ||
C12N 15/82 | (2006.01) | ||
A61P 3/00 | (2006.01) | ||
A61P 43/00 | (2006.01) |
(11) | Number of the document | 3272861 |
(13) | Kind of document | T |
(96) | European patent application number | 17164713.4 |
Date of filing the European patent application | 2011-09-07 | |
(97) | Date of publication of the European application | 2018-01-24 |
(45) | Date of publication and mention of the grant of the patent | 2019-12-18 |
(46) | Date of publication of the claims translation | 2020-03-25 |
(30) | Number | Date | Country code |
201161434499 P | 2011-01-20 | US | |
201161434503 P | 2011-01-20 | US | |
PCT/IL2011/0002 | 2011-03-02 | WO |
(72) |
SHULMAN, Avidor, IL
HANANIA, Uri, IL
KIZHNER, Tali, IL
SHAALTIEL, Yoseph, IL
|
(73) |
Protalix Ltd.,
2 Snunit Street Science Park, 2010000 Carmiel,
IL
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Alfa-galaktozidazės kompozicijos |
ALPHA-GALACTOSIDASE COMPOSITIONS |
Payment date | Validity (years) | Amount | |
2025-08-26 | 15 | 289.00 EUR |
2026-09-07 |